Prognostic Impact of a Past or Synchronous Second Cancer in Diffuse Large B Cell Lymphoma

Blood Cancer Journal - United States
doi 10.1038/s41408-017-0043-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Prognostic Impact of Diffuse Large B-Cell Lymphoma Subgroups in Patients Undergoing Autologous SCT

Bone Marrow Transplantation
TransplantationHematology
2008English

PKC-beta II Expression Has Prognostic Impact in Nodal Diffuse Large B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

Diffuse Large B-Cell Lymphoma

2020English

Prognostic Significance of Serum Aspartic Transaminase in Diffuse Large B-Cell Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Global Hypomethylation Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy